AGILON HEALTH INC (AGL) Stock Analyst Earnings Estimates
NYSE:AGL - New York Stock Exchange, Inc. - US00857U1079 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.708B 47.70% | 4.316B 59.38% | 6.061B 40.41% | 6.01B -0.83% | 6.619B 10.13% | 7.858B 18.72% | 9.248B 17.69% | 10.762B 16.37% | 12.294B 14.24% | 11.624B -5.45% | |
| EBITDA YoY % growth | -106.63M 71.89% | -211.972M -98.79% | -264.071M -24.58% | -104.779M 60.32% | -31.82M 69.63% | 27.002M 184.86% | 139.21M 415.55% | 170.19M 22.25% | 256.54M 50.74% | 363.5M 41.69% | |
| EBIT YoY % growth | -120.4M 69.44% | -232.133M -92.80% | -288.534M -24.30% | -233.105M 19.21% | -164.896M 29.26% | -82.086M 50.22% | -73.528M 10.43% | -12.928M 82.42% | 62.822M 585.94% | 157.36M 150.49% | |
| Operating Margin | -4.45% | -5.38% | -4.76% | -3.88% | -2.49% | -1.04% | -0.80% | -0.12% | 0.51% | 1.35% | |
| EPS YoY % growth | -0.26 75.70% | -0.49 -88.46% | -0.63 -28.57% | -0.35 44.90% | -0.26 23.92% | -0.15 42.30% | 0.24 259.09% | N/A | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 -66.38% | -0.11 61.61% | -0.14 44.54% | 0.01 -66.70% | -0.05 59.41% | -0.07 37.40% | -0.10 29.68% |
| Revenue Q2Q % growth | 1.486B 0.22% | 1.475B 1.66% | 1.505B -1.15% | 1.706B 11.30% | 1.721B 15.81% | 1.718B 16.47% | 1.762B 17.08% |
| EBITDA Q2Q % growth | -28.714M 9.11% | -28.276M 75.53% | -44.397M 44.53% | 28.378M 286.28% | 10.148M 135.34% | -14.339M 49.29% | -38.62M 13.01% |
| EBIT Q2Q % growth | -61.088M -40.94% | -63.448M 52.48% | -75.476M 27.78% | 1.29M 105.83% | -4.141M 93.22% | -49.187M 22.48% | -40.299M 46.61% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 0.03 400.00% | -0.01 | 0.04 | 422.51% |
| Q4 2024 Q2Q % growth | -0.26 36.59% | -0.23 | -0.03 | -12.63% |
| Q3 2024 Q2Q % growth | -0.29 -262.50% | -0.11 | -0.18 | -171.08% |
| Q2 2024 Q2Q % growth | -0.07 -75.00% | -0.08 | 0.01 | 14.11% |
| Q1 2024 Q2Q % growth | -0.01 -125.00% | -0.01 | 0.00 | 18.64% |
| Q4 2023 Q2Q % growth | -0.41 -192.86% | -0.30 | -0.11 | -34.90% |
| Q3 2023 Q2Q % growth | -0.08 -14.29% | -0.06 | -0.02 | -39.16% |
| Q2 2023 Q2Q % growth | -0.04 20.00% | -0.03 | -0.01 | -55.98% |
| Q1 2023 Q2Q % growth | 0.04 | 0.02 | 0.02 | 81.50% |
| Q4 2022 Q2Q % growth | -0.14 | -0.09 | -0.05 | -61.18% |
| Q3 2022 Q2Q % growth | -0.07 22.22% | -0.05 | -0.02 | -38.61% |
| Q2 2022 Q2Q % growth | -0.05 93.67% | -0.02 | -0.03 | -175.03% |
| Q1 2022 Q2Q % growth | 0.00 100.00% | 0.00 | 0.00 | -100.00% |
| Q4 2021 Q2Q % growth | -0.14 | -0.11 | -0.03 | -26.01% |
| Q3 2021 Q2Q % growth | -0.09 | -0.10 | 0.01 | 7.82% |
| Q2 2021 Q2Q % growth | -0.79 | -0.06 | -0.73 | -1,322.14% |
| Q1 2021 Q2Q % growth | -0.05 | -0.03 | -0.02 | -65.02% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 1.533B -4.46% | 1.519B | 13.782M | 0.91% |
| Q4 2024 Q2Q % growth | 1.522B 44.16% | 1.531B | -8.514M | -0.56% |
| Q3 2024 Q2Q % growth | 1.451B 19.35% | 1.485B | -34.068M | -2.29% |
| Q2 2024 Q2Q % growth | 1.483B 29.04% | 1.575B | -92.242M | -5.86% |
| Q1 2024 Q2Q % growth | 1.604B 41.21% | 1.62B | -15.646M | -0.97% |
| Q4 2023 Q2Q % growth | 1.056B 53.10% | 1.028B | 28.073M | 2.73% |
| Q3 2023 Q2Q % growth | 1.216B 74.94% | 1.149B | 66.66M | 5.80% |
| Q2 2023 Q2Q % growth | 1.149B 71.47% | 1.122B | 27.052M | 2.41% |
| Q1 2023 Q2Q % growth | 1.136B 73.88% | 1.089B | 47.147M | 4.33% |
| Q4 2022 Q2Q % growth | 689.8M 49.02% | 671M | 18.8M | 2.80% |
| Q3 2022 Q2Q % growth | 694.9M 51.53% | 660.61M | 34.29M | 5.19% |
| Q2 2022 Q2Q % growth | 670.1M 34.29% | 654.46M | 15.64M | 2.39% |
| Q1 2022 Q2Q % growth | 653.4M 58.17% | 648.65M | 4.75M | 0.73% |
| Q4 2021 Q2Q % growth | 462.9M | 457.42M | 5.48M | 1.20% |
| Q3 2021 Q2Q % growth | 458.6M 46.66% | 454.85M | 3.75M | 0.82% |
| Q2 2021 Q2Q % growth | 499M 69.96% | 478.03M | 20.97M | 4.39% |
| Q1 2021 Q2Q % growth | 413.1M 41.96% | 409.55M | 3.55M | 0.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -85.77% | 0% | 2.33% |
| Revenue | -0.07% | -0.2% | -0.1% | 0.27% |